Gene Reactivation by 5-Aza-2′-Deoxycytidine–Induced Demethylation Requires SRCAP–Mediated H2A.Z Insertion to Establish Nucleosome Depleted Regions

English version České info

5-Aza-2′-deoxycytidine, approved by the FDA for the treatment of myelodysplastic syndrome (MDS), is incorporated into the DNA of dividing cells where it specifically inhibits DNA methylation by forming covalent complexes with the DNA methyltransferases (DNMTs). In an effort to study the correlations between DNA methylation, nucleosome remodeling, and gene reactivation, we investigate the integrated epigenetic events that worked coordinately to reprogram the methylated and closed promoters back to permissive chromatin configurations after 5-Aza-2′-deoxycytidine treatment. The ChIP results indicate that H2A.Z is deposited at promoter regions by the Snf2-related CBP activator protein (SRCAP) complex following DNA demethylation. According to our genome-wide expression and DNA methylation profiles, we find that the complete re-activation of silenced genes requires the insertion of the histone variant H2A.Z, which facilitates the acquisition of regions fully depleted of nucleosome as demonstrated by NOMe–seq (Nucleosome Occupancy Methylome–sequencing) assay. In contrast, SRCAP–mediated H2A.Z deposition is not required for maintaining the active status of constitutively expressed genes. By combining Hpa II digestion with NOMe–seq assay, we show that hemimethylated DNA, which is generated following drug incorporation, remains occupied by nucleosomes. Our data highlight H2A.Z as a novel and essential factor involved in 5-Aza-2′-deoxycytidine–induced gene reactivation. Furthermore, we elucidate that chromatin remodeling translates the demethylation ability of DNMT inhibitors to their downstream efficacies, suggesting future therapeutic implications for chromatin remodelers.

Vyšlo v časopise: Gene Reactivation by 5-Aza-2′-Deoxycytidine–Induced Demethylation Requires SRCAP–Mediated H2A.Z Insertion to Establish Nucleosome Depleted Regions. PLoS Genet 8(3): e32767. doi:10.1371/journal.pgen.1002604
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1002604

Souhrn

Zdroje

1. LugerKMaderAWRichmondRKSargentDFRichmondTJ 1997 Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 389 251 260

2. KellyTKMirandaTBLiangGBermanBPLinJC 2010 H2A.Z maintenance during mitosis reveals nucleosome shifting on mitotically silenced genes. Mol Cell 39 901 911

3. LiBCareyMWorkmanJL 2007 The role of chromatin during transcription. Cell 128 707 719

4. KellyTKDe CarvalhoDDJonesPA 2010 Epigenetic modifications as therapeutic targets. Nat Biotechnol 28 1069 1078

5. SchonesDECuiKCuddapahSRohTYBarskiA 2008 Dynamic regulation of nucleosome positioning in the human genome. Cell 132 887 898

6. RaisnerRMHartleyPDMeneghiniMDBaoMZLiuCL 2005 Histone variant H2A.Z marks the 5′ ends of both active and inactive genes in euchromatin. Cell 123 233 248

7. BarskiACuddapahSCuiKRohTYSchonesDE 2007 High-resolution profiling of histone methylations in the human genome. Cell 129 823 837

8. RangasamyDBervenLRidgwayPTremethickDJ 2003 Pericentric heterochromatin becomes enriched with H2A.Z during early mammalian development. EMBO J 22 1599 1607

9. MorrisonAJShenX 2009 Chromatin remodelling beyond transcription: the INO80 and SWR1 complexes. Nat Rev Mol Cell Biol 10 373 384

10. WongMMCoxLKChriviaJC 2007 The chromatin remodeling protein, SRCAP, is critical for deposition of the histone variant H2A.Z at promoters. J Biol Chem 282 26132 26139

11. CreyghtonMPMarkoulakiSLevineSSHannaJLodatoMA 2008 H2AZ is enriched at polycomb complex target genes in ES cells and is necessary for lineage commitment. Cell 135 649 661

12. JohnSSaboPJJohnsonTASungMHBiddieSC 2008 Interaction of the glucocorticoid receptor with the chromatin landscape. Mol Cell 29 611 624

13. GevryNHardySJacquesPELaflammeLSvotelisA 2009 Histone H2A.Z is essential for estrogen receptor signaling. Genes Dev 23 1522 1533

14. ZofallMFischerTZhangKZhouMCuiB 2009 Histone H2A.Z cooperates with RNAi and heterochromatin factors to suppress antisense RNAs. Nature 461 419 422

15. HardySJacquesPEGevryNForestAFortinME 2009 The euchromatic and heterochromatic landscapes are shaped by antagonizing effects of transcription on H2A.Z deposition. PLoS Genet 5 e1000687 doi:10.1371/journal.pgen.1000687

16. JonesPABaylinSB 2007 The epigenomics of cancer. Cell 128 683 692

17. YangXLayFHanHJonesPA 2010 Targeting DNA methylation for epigenetic therapy. Trends Pharmacol Sci 31 536 546

18. FenauxPMuftiGJHellstrom-LindbergESantiniVFinelliC 2009 Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study. Lancet Oncol 10 223 232

19. JonesPATaylorMS 1980 Cellular Differentiation,Cytidine Analogs and DNA methylation. Cell 20 85 93

20. FandyTE 2009 Development of DNA methyltransferase inhibitors for the treatment of neoplastic diseases. Curr Med Chem 16 2075 2085

21. KomashkoVMFarnhamPJ 2010 5-azacytidine treatment reorganizes genomic histone modification patterns. Epigenetics 5

22. LinJCJeongSLiangGTakaiDFatemiM 2007 Role of nucleosomal occupancy in the epigenetic silencing of the MLH1 CpG island. Cancer Cell 12 432 444

23. NguyenCTWeisenbergerDJVelicescuMGonzalesFALinJC 2002 Histone H3-lysine 9 methylation is associated with aberrant gene silencing in cancer cells and is rapidly reversed by 5-aza-2′-deoxycytidine. Cancer Res 62 6456 6461

24. SiJBoumberYAShuJQinTAhmedS 2010 Chromatin remodeling is required for gene reactivation after decitabine-mediated DNA hypomethylation. Cancer Res 70 6968 6977

25. LiangGChanMFTomigaharaYTsaiYCGonzalesFA 2002 Cooperativity between DNA methyltransferases in the maintenance methylation of repetitive elements. Mol Cell Biol 22 480 491

26. WolffEMByunHMHanHFSharmaSNicholsPW 2010 Hypomethylation of a LINE-1 promoter activates an alternate transcript of the MET oncogene in bladders with cancer. PLoS Genet 6 e1000917 doi:10.1371/journal.pgen.1000917

27. PaulTABiesJSmallDWolffL 2010 Signatures of polycomb repression and reduced H3K4 trimethylation are associated with p15INK4b DNA methylation in AML. Blood 115 3098 3108

28. ZlatanovaJThakarA 2008 H2A.Z: view from the top. Structure 16 166 179

29. HanHCortezCCYangXNicholsPWJonesPA 2011 DNA methylation directly silences genes with non-CpG island promoters and establishes a nucleosome occupied promoter. Hum Mol Genet

30. BibikovaMLeJBarnesBSaedinia-MelnykSZhouL 2009 Genome-wide DNA methylation profiling using Infinium assay. Epigenomics 1 177 200

31. TusherVGTibshiraniRChuG 2001 Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98 5116 5121

32. WuWHAlamiSLukEWuCHSenS 2005 Swc2 is a widely conserved H2AZ-binding module essential for ATP-dependent histone exchange. Nat Struct Mol Biol 12 1064 1071

33. CuadradoACorradoNPerdigueroELafargaVMunoz-CanovesP 2010 Essential role of p18Hamlet/SRCAP-mediated histone H2A.Z chromatin incorporation in muscle differentiation. EMBO J 29 2014 2025

34. ConerlyMLTevesSSDiolaitiDUlrichMEisenmanRN 2010 Changes in H2A.Z occupancy and DNA methylation during B-cell lymphomagenesis. Genome Res

35. ZemachAMcDanielIESilvaPZilbermanD 2010 Genome-wide evolutionary analysis of eukaryotic DNA methylation. Science 328 916 919

36. EdwardsJRO'DonnellAHRollinsRAPeckhamHELeeC 2010 Chromatin and sequence features that define the fine and gross structure of genomic methylation patterns. Genome Res 20 972 980

37. ZilbermanDColeman-DerrDBallingerTHenikoffS 2008 Histone H2A.Z and DNA methylation are mutually antagonistic chromatin marks. Nature 456 125 129

38. JinCZangCWeiGCuiKPengW 2009 H3.3/H2A.Z double variant-containing nucleosomes mark ‘nucleosome-free regions’ of active promoters and other regulatory regions. Nat Genet 41 941 945

39. ChoiJHeoKAnW 2009 Cooperative action of TIP48 and TIP49 in H2A.Z exchange catalyzed by acetylation of nucleosomal H2A. Nucleic Acids Res 37 5993 6007

40. GattaRMantovaniR 2011 NF-Y affects histone acetylation and H2A.Z deposition in cell cycle promoters. Epigenetics 6

41. OkitsuCYHsiehCL 2007 DNA methylation dictates histone H3K4 methylation. Mol Cell Biol 27 2746 2757

42. ThomsonJPSkenePJSelfridgeJClouaireTGuyJ 2010 CpG islands influence chromatin structure via the CpG-binding protein Cfp1. Nature 464 1082 1086

43. VenkatasubrahmanyamSHwangWWMeneghiniMDTongAHMadhaniHD 2007 Genome-wide, as opposed to local, antisilencing is mediated redundantly by the euchromatic factors Set1 and H2A.Z. Proc Natl Acad Sci U S A 104 16609 16614

44. SegalEWidomJ 2009 What controls nucleosome positions? Trends Genet 25 335 343

45. BellOTiwariVKThomaNHSchubelerD 2011 Determinants and dynamics of genome accessibility. Nat Rev Genet 12 554 564

46. ChoyJSWeiSLeeJYTanSChuS 2010 DNA methylation increases nucleosome compaction and rigidity. J Am Chem Soc 132 1782 1783

47. JeongSLiangGSharmaSLinJCChoiSH 2009 Selective anchoring of DNA methyltransferases 3A and 3B to nucleosomes containing methylated DNA. Mol Cell Biol 29 5366 5376

48. ChodavarapuRKFengSBernatavichuteYVChenPYStroudH 2010 Relationship between nucleosome positioning and DNA methylation. Nature 466 388 392

49. Andreu-VieyraCLaiJBermanBPFrenkelBJiaL 2011 Dynamic Nucleosome Depleted Regions at Androgen Receptor Enhancers in the Absence of Ligand in Prostate Cancer Cells. Mol Cell Biol

50. DeobagkarDDLieblerMGraessmannMGraessmannA 1990 Hemimethylation of DNA prevents chromatin expression. Proc Natl Acad Sci U S A 87 1691 1695

51. GonzalgoMLLiangG 2007 Methylation-sensitive single-nucleotide primer extension (Ms-SNuPE) for quantitative measurement of DNA methylation. Nat Protoc 2 1931 1936

52. NguyenCTGonzalesFAJonesPA 2001 Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation. Nucleic Acids Res 29 4598 4606

53. NoushmehrHWeisenbergerDJDiefesKPhillipsHSPujaraK 2010 Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 17 510 522

54. DuPKibbeWALinSM 2008 lumi: a pipeline for processing Illumina microarray. Bioinformatics 24 1547 1548